Who founded Purespring?

Purespring was founded by Moin Saleem in 2020.

Who are Purespring's investors?

Purespring's investors include Sofinnova Partners, Forbion, Gilde Healthcare, Syncona, Advent Life Sciences, British Patient Capital.

Purespring

Founded 2020 · 58 employees on LinkedIn · 7 known investors

Find your way into Purespring

Your email: who you already know at Purespring, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Purespring team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform. The company focuses on preserving kidney function in patients with large, underserved populations affected by renal disease.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Purespring was founded in 2020 by Moin Saleem.

Moin SaleemCo-founder & Chief Scientific Advisor

Investors · 7

Sofinnova Partners✓ confirmed by PurespringParis · $540K – $27M

How we know: Sofinnova Partners's portfolio page · the company's own site · a partner's Signal profile · funding news · press coverage · Not right? Tell us

Forbion✓ confirmed by PurespringNaarden

How we know: the company's own site · funding news · sharecast.com · open dataset · 5k.vc investor directory · Not right? Tell us

Gilde Healthcare✓ confirmed by PurespringUtrecht · $1.1M – $55M

How we know: the company's own site · funding news · sharecast.com · Not right? Tell us

Synconalisted by SynconaLondon

How we know: Syncona's portfolio page · sharecast.com · open dataset · 5k.vc investor directory · Not right? Tell us

Advent Life SciencesreportedLondon

How we know: a partner's Signal profile · Not right? Tell us

British Patient CapitalreportedLondon

How we know: funding news · sharecast.com · Not right? Tell us

Also in the syndicate · 1

Sofinnovalead

In the news

News - Purespring Therapeuticspurespringtx.com · Oct 2025

Purespring Therapeutics raises £80M to develop gene therapies aimed at kidney diseases — TFNtechfundingnews.com · Oct 2024

Purespring Therapeutics Raises $105M in Series B Financingfinsmes.com · Oct 2024

Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases - Purespring Therapeuticspurespringtx.com · Oct 2024

Frequently asked questions

What does Purespring do?: Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform. The company focuses on preserving kidney function in patients with large, underserved populations affected by renal disease.
Who founded Purespring?: Purespring was founded by Moin Saleem in 2020.
Who are Purespring's investors?: Purespring's investors include Sofinnova Partners, Forbion, Gilde Healthcare, Syncona, Advent Life Sciences, British Patient Capital.